Showing results (101-110 of 542) with videos related to
Sort By:
Pageof 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled TrialEthan Basch, Allison M Deal, Mark G Kris, et al.Lung Cancer (Amsterdam, Netherlands)|December 9, 2023
Understanding health-related quality of life measures used in early-stage non-small cell lung cancer clinical trials: A reviewMargarita Majem, Ethan Basch, David Cella, et al.JNCI Cancer Spectrum|August 5, 2021
Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance MarketYa-Chen Tina Shih, Ying Xu, Hui Zhao, et al.Cancer|May 26, 2004
Use of information resources by patients with cancer and their companionsEthan M Basch, Howard T Thaler, Weiji Shi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohortElena B Elkin, Arti Hurria, Nandita Mitra, et al.Gut|March 18, 2015
Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysisJennifer M Yeh, Chin Hur, Zachary Ward, et al.The Annals of Applied Statistics|December 9, 2022
MEASURING PERFORMANCE FOR END-OF-LIFE CARESebastien Haneuse, Deborah Schrag, Francesca Dominici, et al.Advances in Radiation Oncology|September 12, 2018
Palliative radiation and fractionation in medicare patients with incurable non-small cell lung cancerMiranda B Lam, Ling Li, Angel Cronin, et al.Medical Care|August 21, 2002
Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitationsPeter B Bach, Edward Guadagnoli, Deborah Schrag, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancerJeffrey A Meyerhardt, Ling Li, Hanna K Sanoff, et al.Pageof 55